JP2020502183A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502183A5
JP2020502183A5 JP2019532941A JP2019532941A JP2020502183A5 JP 2020502183 A5 JP2020502183 A5 JP 2020502183A5 JP 2019532941 A JP2019532941 A JP 2019532941A JP 2019532941 A JP2019532941 A JP 2019532941A JP 2020502183 A5 JP2020502183 A5 JP 2020502183A5
Authority
JP
Japan
Prior art keywords
salt
amino acid
composition
acid entity
tripeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019532941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020502183A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/067368 external-priority patent/WO2018118957A1/en
Publication of JP2020502183A publication Critical patent/JP2020502183A/ja
Publication of JP2020502183A5 publication Critical patent/JP2020502183A5/ja
Pending legal-status Critical Current

Links

JP2019532941A 2016-12-19 2017-12-19 アミノ酸組成物ならびに筋肉疾患および障害の治療方法 Pending JP2020502183A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201662436073P 2016-12-19 2016-12-19
US62/436,073 2016-12-19
US201762443205P 2017-01-06 2017-01-06
US62/443,205 2017-01-06
US201762491776P 2017-04-28 2017-04-28
US62/491,776 2017-04-28
US201762545358P 2017-08-14 2017-08-14
US62/545,358 2017-08-14
US201762576321P 2017-10-24 2017-10-24
US62/576,321 2017-10-24
PCT/US2017/067368 WO2018118957A1 (en) 2016-12-19 2017-12-19 Amino acid compositions and methods for the treatment of muscle diseases and disorders

Publications (2)

Publication Number Publication Date
JP2020502183A JP2020502183A (ja) 2020-01-23
JP2020502183A5 true JP2020502183A5 (enExample) 2021-02-12

Family

ID=61025047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019532941A Pending JP2020502183A (ja) 2016-12-19 2017-12-19 アミノ酸組成物ならびに筋肉疾患および障害の治療方法

Country Status (21)

Country Link
US (3) US20180207119A1 (enExample)
EP (1) EP3554493A1 (enExample)
JP (1) JP2020502183A (enExample)
KR (1) KR20190099243A (enExample)
CN (1) CN110267655A (enExample)
AU (1) AU2017379825A1 (enExample)
BR (1) BR112019012476A2 (enExample)
CA (1) CA3046558A1 (enExample)
CL (1) CL2019001685A1 (enExample)
CO (1) CO2019006292A2 (enExample)
CU (1) CU20190057A7 (enExample)
EC (1) ECSP19043725A (enExample)
IL (1) IL267210A (enExample)
JO (1) JOP20190147A1 (enExample)
MA (1) MA50763A (enExample)
MX (1) MX2019007352A (enExample)
PE (1) PE20191206A1 (enExample)
PH (1) PH12019501339A1 (enExample)
TW (1) TWI780096B (enExample)
WO (1) WO2018118957A1 (enExample)
ZA (1) ZA201903581B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US11617731B2 (en) 2017-04-28 2023-04-04 Axcella Health, Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
WO2019036442A1 (en) * 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF NEURONAL INJURY
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
KR20210023846A (ko) 2018-06-20 2021-03-04 악셀라 헬스 인크. 아미노산 조성물을 제조하는 방법
CN112839712A (zh) * 2018-06-20 2021-05-25 胺细拉健康公司 用于减少或治疗发炎的组合物和方法
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CN112752575A (zh) * 2018-09-27 2021-05-04 雀巢产品有限公司 组氨酸、甘氨酸和其它氨基酸用于预防胰岛素抗性和/或糖尿病的用途
BR112021021537A2 (pt) * 2019-06-07 2022-04-19 Nestle Sa Composições e métodos que usam um ou mais aminoácidos indutores de autofagia para potencializar o efeito músculo-esquelético de um ou mais aminoácidos anabólicos
US20220184015A1 (en) * 2019-06-20 2022-06-16 Societe Des Produits Nestle S.A. Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids on bone health
KR102456270B1 (ko) * 2019-09-24 2022-10-19 마이오텍사이언스 주식회사 비천연 아미노산 유도체를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물
KR102338447B1 (ko) * 2019-09-24 2021-12-14 마이오텍사이언스 주식회사 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물
US20220331290A1 (en) * 2019-09-24 2022-10-20 Myo-Tec-Sci Pharmaceutical composition for preventing or treating sarcopenia, containing unnatural amino acid
CN110801007A (zh) * 2019-12-17 2020-02-18 苟春虎 老年肌少症营养肽
US20230089723A1 (en) * 2020-03-06 2023-03-23 Axcella Health Inc. Amino acid compositions and methods for muscle and myotube modulation
US20230390234A1 (en) * 2021-02-26 2023-12-07 Ex Healthcare Inc. Composition inhibiting muscle loss or promoting muscle formation through skin-derived exosomes
CN113288890B (zh) * 2021-06-21 2022-02-22 南方医科大学南方医院 N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用
WO2024026307A1 (en) 2022-07-25 2024-02-01 Axcella Health Inc. Biomarker for long covid and fatigue
WO2024030909A1 (en) 2022-08-01 2024-02-08 Axcella Health Inc. Biomarkers of amino acid composition treatment response in long covid
WO2025167857A1 (zh) * 2024-02-06 2025-08-14 南京纽邦生物科技有限公司 用于增强或改善肌肉功能和/或提高运动表现和/或预防或缓解疲劳的方法和组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02007466A (es) * 2000-02-01 2004-02-26 Muscletech Res And Dev Inc Suplemento alimenticio a base de acido alfa-lipoico para incrementar la masa muscular escas y la fuerza.
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
WO2006009975A2 (en) * 2004-06-22 2006-01-26 Maxim Pharmaceuticals, Inc. Histamine to treat disorders affecting muscle function
JP5545424B2 (ja) * 2005-03-29 2014-07-09 味の素株式会社 高齢者の骨格筋量減少を防止又は改善するためのアミノ酸含有組成物
JP2007023921A (ja) * 2005-07-19 2007-02-01 Toyota Motor Corp 内燃機関の制御装置
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
CN100518815C (zh) * 2007-02-15 2009-07-29 北京苏里曼医药科技有限公司 一种氨基酸组合物
AU2012299126B2 (en) * 2011-08-19 2016-05-26 Musclepharm Corporation Compositions and methods for use in promoting lean body mass
WO2015061607A1 (en) * 2013-10-23 2015-04-30 Whitehead Institute For Biomedical Research Mtorc1 modulation by amino acids and uses thereof

Similar Documents

Publication Publication Date Title
JP2020502183A5 (enExample)
TWI780096B (zh) 胺基酸組合物及肌肉疾病與病症之治療方法
ES2221385T3 (es) Preparaciones de gabapentina y pregabalina estabilizadas con aminoacidos y procedimiento para prepararlas.
US7645796B2 (en) Amino acid composition promoting collagen synthesis
WO2005017094A3 (en) N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency
CN108721596B (zh) 一种复方氨基酸维生素注射液及其应用
JP2013516464A5 (enExample)
RU2008126294A (ru) Способы лечения потери мышечной массы
JP2006522821A5 (enExample)
JPS61247354A (ja) 栄養素組成物
WO2021178860A1 (en) Amino acid compositions and methods for muscle and myotube modulation
JPWO2019036471A5 (enExample)
Johannessen et al. The acute effect of valproate on cerebral energy metabolism in mice
ATE541568T1 (de) Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten
JP2006524182A5 (enExample)
JPWO2000043035A1 (ja) アミノ酸含有アルブミン製剤
JPWO2019246225A5 (enExample)
NZ723300A (en) Compositions for the prevention and/or treatment of pathologies associated with alpha-glucosidase
RU2008123806A (ru) Лекарственное средство, применяющееся при поражениях хряща
WO1995022967A1 (en) Analgesic activity enhancer
RU2017489C1 (ru) Лекарственное средство для парентерального питания и дезинтоксикации
OA19826A (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
JPWO2022251624A5 (enExample)
FI3989999T3 (fi) Haaraketjuisia aminohappoja käsittävä uusi koostumus
KR960000068B1 (ko) 영양소 조성물의 제조방법